692 Impact of Body Mass Index on Efficacy of Infliximab in Children With Inflammatory Bowel Disease
Document Type
Article
Publication Date
5-2013
Repository Citation
Grossi, V.,
Lerer, T.,
Markowitz, J.,
Griffiths, A.,
Evans, J.,
Bousvaros, A.,
Mack, D. R.,
Otley, A.,
Pfefferkorn, M.,
Rosh, J.,
Oliva-Hemker, M.,
Saeed, S. A.,
Deslandres, C.,
Carvalho, R.,
Grossman, A.,
Keljo, D.,
Kappelman, M.,
Hitch, M. C.,
Sudel, B.,
James, R.,
Cabrera, J.,
Faubion, W.,
Leleiko, N.,
& Hyams, J. S.
(2013). 692 Impact of Body Mass Index on Efficacy of Infliximab in Children With Inflammatory Bowel Disease. Gastroenterology, 144 (5), Supplement 1:S.
https://corescholar.libraries.wright.edu/pediatrics/594
DOI
10.1016/S0016-5085(13)60459-X
